https://www.selleckchem.com/pr....oducts/bay-2413555.h
Owing to its rarity and heterogeneity, the biological behavior and optimal therapeutic management of mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) have not been established. Herein, we aimed to evaluate the clinicopathological characteristics and metastatic patterns of MiNEN. Continuous clinicopathological data of MiNEN patients treated at our hospital were retrospectively collected and analyzed. This study had enrolled 169 patients since January 2010 to January 2020. Pathological components were assessed in 129 patients